Three manufacturers of duodenoscopes associated with contamination incidents over the past three years must conduct postmarket surveillance studies so FDA can evaluate how the devices are being reprocessed between procedures and determine how best to reduce infection risks, the agency ordered on Oct. 5.
Under the order, Olympus America, Inc., Fujifilm Medical Systems USA Inc. and Hoya Corp
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?